51 |
Appraisal of models for the study of disease progression in psoriatic arthritisAguirre-Hernandez, Rebeca January 2000 (has links)
No description available.
|
52 |
An investigation into the roles of lysosomal proteinases, particularly cathepsin B, in cartilage proteoglycan degradationAdcocks, Clair January 1999 (has links)
No description available.
|
53 |
Clinical and Genetic Studies in Becker Muscular DystrophySkinner, R. January 1975 (has links)
No description available.
|
54 |
Immune responses to dystrophin : implications for gene therapy of DMDFerrer Roig, Aurora January 2001 (has links)
No description available.
|
55 |
Analysis of the mechanisms of immune gene therapy in a murine model for rheumatoid arthritisDreja, Hanna Stina January 2000 (has links)
No description available.
|
56 |
Bioactive glasses for delivery of nitric oxide for enhanced osteogenesisPryce, Russell Stuart January 2003 (has links)
No description available.
|
57 |
Effect of age on fracture healingShroff, Malav January 2000 (has links)
No description available.
|
58 |
Occupational risk factors for meniscal injuryBaker, Paul January 2000 (has links)
No description available.
|
59 |
Development of an individualised patient-centred instrument to measure minimum clinically important fifference in low back painMullis, Ricky January 2007 (has links)
LoW back pain is a commo'n, recurrent problem, with many sufferers going on to develop long-term disability and work absence. A number of potential patho- ' anatomical pathways may give rise to low back pain, although the aetiology of a specific episode is often unclear. Management options range from simple analgesia and physiotherapy, to major spinal surgery.Clinical trials often fail to show significant long term differences in outcome between treatment options for low back pain. Measuring the course of this fluctuating condition is problematic, and often what matters to patients is not reflected in standardised clinical outcomes. This thesis describes the development of an individualised approach to outcome measurement which captures changes that are important to patients with low back pain.
|
60 |
Bone marrow stromal cells for the treatment of established fracture non-unionBajada, Stefan January 2011 (has links)
No description available.
|
Page generated in 0.0135 seconds